Reshaping the immunosuppressive niche in hepatocellular carcinoma: crosstalk networks, metabolic reprogramming, and therapeutic strategies.
TL;DR
This review integrates recent advances in understanding the multifaceted mechanisms of immune evasion in HCC, including dysregulated immune cell interactions, metabolic adaptations that reshape immune function, and early activation of inhibitory checkpoints to provide a foundational framework for advancing strategies to overcome HCC's immunosuppressive ecosystem.
OpenAlex 토픽 ·
Hepatocellular Carcinoma Treatment and Prognosis
Cancer, Hypoxia, and Metabolism
Liver physiology and pathology
This review integrates recent advances in understanding the multifaceted mechanisms of immune evasion in HCC, including dysregulated immune cell interactions, metabolic adaptations that reshape immune
APA
Yuting ZHANG, Shizheng Xiong, et al. (2026). Reshaping the immunosuppressive niche in hepatocellular carcinoma: crosstalk networks, metabolic reprogramming, and therapeutic strategies.. Biochemical pharmacology, 248, 117858. https://doi.org/10.1016/j.bcp.2026.117858
MLA
Yuting ZHANG, et al.. "Reshaping the immunosuppressive niche in hepatocellular carcinoma: crosstalk networks, metabolic reprogramming, and therapeutic strategies.." Biochemical pharmacology, vol. 248, 2026, pp. 117858.
PMID
41794264
Abstract
The liver tumor microenvironment plays a pivotal role in hepatocellular carcinoma (HCC) progression by fostering immune suppression, which impairs anti-tumor responses and enables tumor growth, invasion, and metastasis. This review integrates recent advances in understanding the multifaceted mechanisms of immune evasion in HCC, including dysregulated immune cell interactions, metabolic adaptations that reshape immune function, and early activation of inhibitory checkpoints. Key contributors such as regulatory immune subsets and stromal elements are examined, alongside emerging insights into pre-metastatic niches and metabolic barriers. The review also evaluates current immunotherapeutic approaches targeting these mechanisms, highlighting clinical progress, challenges, and opportunities for precision interventions. By synthesizing these elements, this work provides a foundational framework for advancing strategies to overcome HCC's immunosuppressive ecosystem.
MeSH Terms
Humans; Carcinoma, Hepatocellular; Liver Neoplasms; Tumor Microenvironment; Animals; Immunotherapy; Metabolic Reprogramming
같은 제1저자의 인용 많은 논문 (5)
- Comment on: "Interpretable machine learning model for predicting early recurrence of pancreatic cancer: integrating intratumoral and peritumoral radiomics with body composition".
- Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in -amplified gastric cancer.
- Impact of contrast-enhanced computed tomography surveillance frequency on survival outcomes in patients with stage I-III colorectal cancer: A propensity score-matched retrospective cohort study.
- Corrigendum to "TMEM176A drives anti-apoptotic signaling through TGM2-mediated ERK activation in gastric cancer" [Int. Immunopharmacol. 168 (2026) 115798].
- Dietary restriction genes as modulators of breast cancer risk through metabolic pathways.